Bevacizumab/carboplatin/vinorelbineLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1917卷 / 1期

关键词：

D O I：

10.1007/s40278-022-19999-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：128 / 128

相关论文

共 50 条

[1] Carboplatin/nivolumab/vinorelbineLack of efficacy: case report
Reactions Weekly, 2023, 1938 (1) : 366 - 366
[2] VinorelbineLack of efficacy: case report
Reactions Weekly, 2021, 1869 (1) : 338 - 338
[3] Carboplatin/paclitaxel/vinorelbineLack of efficacy: 2 case reports
Reactions Weekly, 2022, 1923 (1) : 128 - 128
[4] Bevacizumab/carboplatin/pemetrexedLack of efficacy: case report
Reactions Weekly, 2023, 1983 (1) : 107 - 107
[5] Bevacizumab/carboplatin/doxorubicinLack of efficacy: case report
Reactions Weekly, 2023, 1965 (1) : 118 - 118
[6] Bevacizumab/carboplatin/paclitaxelLack of efficacy: case report
Reactions Weekly, 2022, 1904 (1) : 119 - 119
[7] Bevacizumab/carboplatin/pemetrexedLack of efficacy: case report
Reactions Weekly, 2022, 1907 (1) : 110 - 110
[8] Bevacizumab/carboplatin/paclitaxelLack of efficacy: case report
Reactions Weekly, 2022, 1915 (1) : 100 - 100
[9] Gemcitabine/VinorelbineLack of efficacy: case report
Reactions Weekly, 2024, 2037 (1) : 190 - 190
[10] Cisplatin/vinorelbineLack of efficacy: case report
Reactions Weekly, 2023, 1953 (1) : 148 - 148

← 1 2 3 4 5 →